TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Proteomics International Laboratories Ltd. ( (AU:PIQ) ) has shared an announcement.
Proteomics International Laboratories Ltd announced the issuance of 375,000 unquoted equity securities, specifically options expiring on June 6, 2027, with an exercise price of $0.555. This issuance is part of a previously announced transaction, and these securities are not intended to be quoted on the ASX. The move reflects the company’s ongoing efforts to manage its equity and financial strategy, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (AU:PIQ) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd is a company operating in the biotechnology industry, specializing in the development and commercialization of diagnostic tests and analytical services. The company focuses on proteomics, the large-scale study of proteins, which plays a crucial role in understanding diseases and developing new diagnostic tools.
Average Trading Volume: 363,682
Technical Sentiment Signal: Sell
Current Market Cap: A$61.38M
Find detailed analytics on PIQ stock on TipRanks’ Stock Analysis page.